Evolution and development of the diagnosis and treatment of adenocarcinoma of esophagogastric junction: from the perspective of a general surgeon
10.3760/cma.j.cn115610-20200527-00389
- VernacularTitle:从腹部外科医师的视角审视食管胃结合部腺癌诊断与治疗策略之演变发展趋势
- Author:
Enhao ZHAO
1
;
Hui CAO
Author Information
1. 上海交通大学医学院附属仁济医院胃肠外科 200127
- From:
Chinese Journal of Digestive Surgery
2020;19(6):598-603
- CountryChina
- Language:Chinese
-
Abstract:
The incidence of adenocarcinoma of esophagogastric junction (AEG) is increasing worldwide annually. Surgical resection still plays the most important role in multi-modality therapy for AEG. However, due to the specialities of tumor location and biological features, general surgeons and thoracic surgeons do not reach an agreement on regional lymph-adenectomy, extents of resection, surgical approaches, etc. The development of minimally invasive surgery makes it possible to operate by laparoscopy and thoracoscopy. With the promotion of neoadjuvant therapy, a multidisciplinary team will be essential for optimal diagnosis and treatment in the near future. From the developmental perspective of a general surgeon, the authors summarize current status and controversies of the diagnosis and treatment of AEG, and inspect its research advances.
